EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II

Anja Smits, Brigitta G Baumert

International Journal of Molecular Imaging · 2011

DOI: 10.1155/2011/372509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Imaging, 2011. Verfasst von Anja Smits und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Neurology, University Hospital, Uppsala University, 751 85 Uppsala, Sweden. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Uppsala University, Lions Cancer Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical management of adults with low-grade gliomas (LGGs) remains a challenge. There is no curative treatment, and management of individual patients is a matter of deciding optimal timing as well as right treatment modality. In addition to conventional imaging techniques, positron emission tomography (PET) with amino acid tracers can facilitate diagnostic and therapeutic procedures. In this paper, the clinical applications of PET with amino acid tracers 11 C-methyl-L-methionine (MET) and 18 F-fluoro-ethyl-L-tyrosine (FET) for patients with LGG are summarized. We also discuss the value of PET for the long-term followup of this patient group. Monitoring metabolic activity by PET in individual patients during course of disease will provide insight in the biological behavior and evolution of these tumors. As such, spatial changes in tumor activity over time, including shifts of hot-spot regions within the tumor, may reflect intratumoral heterogeneity and correlate to clinical parameters.

Autor:innen und Institutionen

  • Department of Neuroscience, Neurology, University Hospital, Uppsala University, 751 85 Uppsala, Sweden.

Förderung

  • Uppsala University
  • Lions Cancer Foundation

Zitieren

APA

Smits, A., & Baumert, B. G. (2011). The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II. International Journal of Molecular Imaging. https://doi.org/10.1155/2011/372509

Vancouver

Smits A, Baumert BG. The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II. International Journal of Molecular Imaging. 2011. doi:10.1155/2011/372509

BibTeX
@article{Smits2011,
  author = {Smits, Anja and Baumert, Brigitta G},
  title = {The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II},
  journal = {International Journal of Molecular Imaging},
  year = {2011},
  doi = {10.1155/2011/372509}
}
Kostenlos starten →